Hospitalization – Page 19 – Communicable Diseases Research

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world

Article

Published on 2022-10-032022-11-16
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome appear approval approved coronavirus coronavirus disease country COVID-19 COVID-19 outbreak COVID-19 vaccine death deaths delta variant disease disease severity distribution drug Effect effective Effectiveness effort Emergency use fatality health emergency health system healthcare hospitalisation Hospitalization individual Omicron variant Omicron variants outbreak pandemic Prevent PROTECT provided reduced remained researcher SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severe disease severity Spread Uncertainty vaccination Vaccine Vaccine development vaccine platform Vaccines variant variant of concern World Health Organisation
[DOI] 10.3389/fimmu.2022.961198 PMC 바로가기

Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England

Article

Published on 2022-10-032022-11-16
Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종,

[키워드] 30-Day mortality 95% CI accounted adjusted adjusted odds ratio Admission Admissions age Analysis appear applied approach assigned B.1.1.529 B.1.617.2 cohort study confirmed COVID-19 case confounders confounding factor COVID-19 Delta delta variant England estimate Factor Hospitalization infections intensive care intrinsic intrinsically invasive ventilation less Lineage Longitudinal data mass Mortality multicenter New occurred omicron outcome outcomes retrospective cohort study risk SARS-CoV-2 secondary severity significantly Vaccinations variant variants variety were excluded with COVID-19 women
[DOI] 10.1001/jamanetworkopen.2022.38354 PMC 바로가기

Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study

Article

Published on 2022-10-022022-11-16
Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 변종,

Headache as a COVID-19 onset symptom and post-COVID-19 symptom in hospitalized COVID-19 survivors infected with the Wuhan, Alpha, or Delta SARS-CoV-2 variants

Article

Published on 2022-10-012022-11-16
Journal: Headache [Category] COVID19(2023년), SARS, 변종,

Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view

Article

Published on 2022-10-012022-11-15
Journal: Inflammopharmacology [Category] COVID19(2023년), SARS, 변종, 치료제,

Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study

Clinical Trial

Published on 2022-10-012022-10-05
Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 임상, 진단,

Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge

Article

Published on 2022-10-012022-11-15
Journal: American journal of transplantation : official jou [Category] COVID19(2023년), SARS, 진단, 치료제,

IL-6 drives T cell death to participate in lymphopenia in COVID-19

Research article

Published on 2022-10-012022-10-05
Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 임상, 치료기술,

Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial

Research article

Published on 2022-10-012022-10-05
Journal: European Journal of Integrative Medicine [Category] 바이오마커, 임상,

[키워드] acute respiratory syndrome Antiviral treatment appear approved baseline characteristics C-reactive protein cause caused Cicer Cicer arietinum Clinical outcome clinical trial Combination conducted control group cough COVID-19 COVID-19 patient COVID-19 patients demographics develop diagnosis of COVID-19 diet double-blind education Effect effective Efficacy and safety Ficus ficus carica headache help Hospitalization Inflammatory biomarker Inflammatory marker Intervention intervention group Iran Laboratory life-threatening Medicine Ministry of Health myalgia no significant difference Organ failure Patient randomized clinical trial randomized, controlled trial regimen Research Result Reza Safflower Sample size SARS-CoV-2 significant difference significantly lower SPSS software statistical analysis supportive care Symptom Symptoms Tehran Traditional traditional Persian medicine Treatment treatment period Treatment protocol variables virus Vitis Vitis vinifera weakness while
[DOI] 10.1016/j.eujim.2022.102179 [Article Type] Research article

Efficacy of COVID-19 vaccines

Observational Study

Published on 2022-10-012023-07-10
Journal: Microbial pathogenesis [Category] COVID19(2023년),

[키워드] coronavirus COVID-19 Hospitalization Infection Mortality Vaccines
[DOI] 10.1016/j.micpath.2022.105729 PMC 바로가기 [Article Type] Observational Study